Cargando…

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

BACKGROUND: Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic value for cardiovascular risk stratification across different patient populations. The incremental value of Cys‐C beyond established cardiac and renal biomarkers remains incompletely explored. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correa, Simon, Morrow, David A., Braunwald, Eugene, Davies, Richard Y., Goodrich, Erica L., Murphy, Sabina A., Cannon, Christopher P., O'Donoghue, Michelle L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474969/ https://www.ncbi.nlm.nih.gov/pubmed/30371283 http://dx.doi.org/10.1161/JAHA.118.009077

Ejemplares similares

Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
por: Fanola, Christina L., et al.
Publicado: (2017)

Multimarker Risk Stratification in Patients With Acute Myocardial Infarction
por: O'Donoghue, Michelle L., et al.
Publicado: (2016)

Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial
por: Eisen, Alon, et al.
Publicado: (2017)

Cystatin C in the prognostic stratification of patients with an acute coronary syndrome
por: Lago, A Lopez, et al.
Publicado: (2007)

Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary Syndrome
por: Barger, Laura K., et al.
Publicado: (2017)

Coronary artery calcium and cystatin C for risk stratification of MACCEs and all‐cause death in symptomatic patients
por: Luo, Fan, et al.
Publicado: (2022)

Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease
por: Lees, Jennifer S., et al.
Publicado: (2022)

Cystatin C in Acute Coronary Syndrome
por: Lodh, Moushumi, et al.
Publicado: (2013)

Role for Cystatin C–Based Risk Stratification for Patients After Acute Coronary Syndrome in the Era of High Sensitivity Cardiac Troponin Assays
por: Latta, Federica, et al.
Publicado: (2018)

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes
por: Røysland, Ragnhild, et al.
Publicado: (2012)

Dynamic TIMI Risk Score for STEMI
por: Amin, Sameer T., et al.
Publicado: (2013)

Cystatin C regulates the cytotoxicity of infection‐induced endothelial‐derived β‐amyloid
por: Balczon, Ron, et al.
Publicado: (2020)

Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes
por: Zelniker, Thomas A., et al.
Publicado: (2019)

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
por: Zelniker, Thomas A., et al.
Publicado: (2021)

Cystatin C Is Not Causally Related to Coronary Artery Disease
por: Svensson-Färbom, Patrik, et al.
Publicado: (2015)

Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary Syndrome
por: Chisholm, Jeffrey W., et al.
Publicado: (2010)

Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification
por: Zamora, Elisabet, et al.
Publicado: (2012)

Plasma Omega‐3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN‐TIMI 36
por: Zelniker, Thomas A., et al.
Publicado: (2021)

The Incidence of Kidney Injury for Patients Treated With a High‐Potency Versus Moderate‐Potency Statin Regimen After an Acute Coronary Syndrome
por: Sarma, Amy, et al.
Publicado: (2014)

Cystatin C–Adiponectin Complex in Plasma Associates with Coronary Plaque Instability
por: Matsumoto, Akane, et al.
Publicado: (2017)

A New Perspective for Isolated Coronary Artery Ectasia: Cystatin C
por: Karakus, Alper, et al.
Publicado: (2020)

Impact of Growth Hormone on Cystatin C
por: Sze, Lisa, et al.
Publicado: (2013)

Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity
por: Kim, J-T, et al.
Publicado: (2013)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Cystatin C and Cystatin SN As Possible Soluble Tumor Markers in Malignant Uveal Melanoma
por: Dikovskaya, Maria A., et al.
Publicado: (2021)

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
por: Kato, Eri Toda, et al.
Publicado: (2017)

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
por: Kato, Eri Toda, et al.
Publicado: (2022)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Cystatin C in Alzheimer's disease
por: Kaur, Gurjinder, et al.
Publicado: (2012)

Cystatin C uptake in the eye
por: Wassélius, Johan, et al.
Publicado: (2004)

Cystatin C and uncontrolled hypertension
por: Omaygenç, Mehmet Onur, et al.
Publicado: (2020)

Cardiovascular Events and Long‐Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE‐IT
por: Fordyce, Christopher B., et al.
Publicado: (2022)

Corticosteroids significantly increase cystatin C levels in the plasma by promoting cystatin C production in rats
por: Zhu, Xiao-Ran, et al.
Publicado: (2019)

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial
por: Murphy, Sabina A., et al.
Publicado: (2008)

Association of serum cystatin C levels with acute coronary syndrome in patients of advanced age
por: Huang, Qingyu, et al.
Publicado: (2019)

Association of cystatin C with coronary artery calcification in patients undergoing multidetector computed tomography
por: Xiong, Hui, et al.
Publicado: (2021)

Serum cystatin C predicts the risk of non-ST-elevation acute coronary syndrome
por: Dong, Hao, et al.
Publicado: (2023)

Involvement of cystatin C in immunity and apoptosis
por: Zi, Mengting, et al.
Publicado: (2018)

Cystatin C: A Primer for Pharmacists
por: Teaford, Hilary R., et al.
Publicado: (2020)

Role of cystatin C in urogenital malignancy
por: Ding, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3pia94qcr3rmau5o7jq8sjjc3